NCT04118166View on ClinicalTrials.gov

Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

April 26, 2022

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Ipilimumab

Ipilimumab 1 mg/kg, injection

PROCEDURE

Cryoablation

Cryoablation of the tumors occur between investigational agent treatment Cycles 1 and 2, and will be performed according to standard procedures

DRUG

Nivolumab

Nivolumab 3 mg/kg, injection

Trial Locations (1)

94304

Stanford Medical Center, Stanford

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Kristen Ganjoo

OTHER